Idevax
Idevax is an ISO13485 certified medical device company based in Antwerp, Belgium, founded in December 2020. Our company develops, produces, and commercializes innovative drug delivery medical devices used for cell and gene therapies, prophylactic and therapeutic vaccine delivery as well as immunotherapy.
Our flagship product is VAX-ID, a device platform allowing for accurate, reliable and user-independent skin drug delivery with a high ease of use. VAX-ID is an award-winning, patented device. The device is currently available for investigational use. CE marking as well as FDA approval are expected early 2025.
Idevax has in-house manufacturing capabilities for its drug delivery devices, including clean room facilities, a QC as well as R&D laboratory and warehousing.
The Idevax highly multidisciplinary and complementary team consists of 9 people. The team covers for all aspects related to medical device development of drug delivery devices, preclinical R&D, Quality Assurance, Regulatory Affairs, clinical trials, business development and marketing.
Ceva
Ceva Santé Animale is the 5th largest global animal health company,
led by experienced veterinarians, whose mission is to provide
innovative health solutions for all animals to ensure the highest level of care and well-being. The company is headquartered in Libourne, France.
With more than 7,000 employees located in 47 countries, Ceva Santé Animale strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”.
The companie’s 21 R&D centers and 33 production sites worldwide attest to its commitment to research and the development of increasingly innovative solutions.
ABG - Association Bernard Gregory
ABG is a French non-profit organization with 44 years of experience in career development and facilitating the recruitment of Ph.D. holders across all fields. Its network includes private companies (SMEs & LEs), public and private research labs and centers, universities, and professional associations.
ABG provides quality communication on doctoral careers and insights through its website and social media, organizes events, and fosters connections between researchers and employers. Since 2008, ABG has expanded its focus to include researcher mobility at the European and international levels, offering training and recruitment services to partners in Belgium, Italy, Luxembourg, Spain, Germany, Canada, and the United States.
In 2017, ABG was designated as a “Career Development Center” by Euraxess and has been actively contributing to the network ever since.
Miltenyi Biotec
Miltenyi Biotec is one of Germany’s most successful biotechnology companies. Since its foundation in 1989, it has grown to more than 4900 employees worldwide. Our multidisciplinary R&D department consists of 1150 scientists, technicians, and engineers and is constantly developing novel reagents and instruments for use in immunology, hematology, cell biology, and molecular biology.
For technical support and overnight delivery of its products, Miltenyi has more than 25 sales Offices and an extensive network of distributors in leading industrial countries worldwide. Magnetic Cell Sorting Technology (MACS® Technology), originally developed by Stefan Miltenyi to become its first product, has evolved to an established standard method in biomedical research and in novel clinical approaches such as cellular immunotherapy or regenerative medicine.
With MACS Technology, virtually any cell type can be isolated from human and animal cells to plant cells and bacteria. Consequently, Miltenyi Biotec develops, produces, and markets more than 19000 state-of-the-art products and services focusing on sample preparation, cell separation, cell culture, flow cytometry, and clinical applications in the field of cell therapy.
Miltenyi has a great aptitude to drive scientific concepts to clinical products that are well-accepted by the community of researchers and clinicians adapting them to regulatory requirements, well demonstrated by the recent FDA approval for a clinical application using the companys CliniMACS CD34 reagent.
Institute of ImplantTechnology
and Biomaterials
Since 1996, the Institute of ImplantTechnology and Biomaterials
(IIB e.V.) is established as a research and development partner, but also as a service provider for the medical technology industry as well as for companies and research institutions in related high-tech fields.
The IIB e.V. is delighted to address the industry’s needs and challenges in the development of innovative medical products and technologies.
By supporting regional industry and working closely with universities, the institute actively contribute to the sustainable development of Mecklenburg-Vorpommern as a forward-looking technology center in Germany with international recognition.
VitalFluid
VitalFluid, a spin-off company from the Eindhoven University of technology, is specialized in technology and applications of plasma-activated water (PAW). We develop customer-driven PAW applications focusing on seed treatment, crop protection, and nitrogen fixation in agriculture.
Understanding the physical and chemical processes in PAW and the ability to control, enrich and scale up the activation processes strengthens our position in the market. We work in close cooperation with end-users, customers, and several universities in the Netherlands, Belgium, the USA, and Germany.
CORTRONIK
The CORTRONIK GmbH is part of the worldwide acting BIOTRONIK Group. In close cooperation with the BIOTRONIK AG in Bülach, Switzerland, about 300 employees work in Rostock-Warnemünde (Germany) to develop and produce vascular stent & scaffold implants for coronary and peripheral applications.
CORTRONIK was founded in 1998 in close cooperation with the University of Rostock. Due to our portfolio spanning research and development, testing of implants, and production of stents & scaffolds, CORTRONIK constitutes the metal competence center within the BIOTRONIK group.
Molecular Plasma Group
The Molecular Plasma Group (MPG) was founded in 2016 as a spin-off company from the Flemish Institute for Technological Research (VITO), located in Brussels. Its core competence is surface modification, based on dedicated plasma equipment design, construction, and servicing.
MPG offers plasma equipment ranging from lab systems for R&D centers and universities to in-line industrial systems for continuous production. The markets where MPG is active are diverse, ranging from, e.g., automotive to aeronautic, printing, packaging, biotechnology, and health and medical devices.
